Home
/
Pelthos Therapeutics Inc.
/
Financials
/
Quarterly
Pelthos Therapeutics Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Pelthos Therapeutics Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$7.41M
Nov 13, 2025
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$294.0K
Nov 13, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($16.24M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($3.45M)
Aug 13, 2025
Q3
2025
Jun 30, 2025
($3.45M)
Nov 13, 2025
Q2
2025
Mar 31, 2025
($1.97M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($1.97M)
May 13, 2025
Q3
2025
Mar 31, 2025
($1.97M)
Nov 13, 2025
Q3
2025
Sep 30, 2024
($1.70M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($1.77M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($1.77M)
Aug 13, 2025
Q2
2025
Mar 31, 2024
($2.56M)
Aug 13, 2025
Q3
2025
Mar 31, 2024
($2.56M)
Nov 13, 2025
Q1
2025
Mar 31, 2024
($2.56M)
May 13, 2025
Q3
2024
Sep 30, 2023
($1.42M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($953.3K)
Aug 13, 2024
Q3
2024
Jun 30, 2023
($953.3K)
Nov 13, 2024
Q2
2024
Mar 31, 2023
($966.6K)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($966.6K)
Nov 13, 2024
Q1
2024
Mar 31, 2023
($966.6K)
May 15, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($15.36M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($3.23M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($1.83M)
May 13, 2025
Q3
2025
Sep 30, 2024
($2.05M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($1.76M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($1.93M)
May 13, 2025
Q3
2024
Sep 30, 2023
($1.29M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($777.2K)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($914.6K)
May 15, 2024